Generic Animal Drug Advancement Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 15, 2022)
Generic Animal Drug Advancement Act
This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)
What just happenedSep 16, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseSep 15, 2022
- Sep 16, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 15, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 15, 2022IntroReferralIntro-H
Introduced in House
- Sep 15, 2022IntroReferral1000
Introduced in House